A nationwide recall has been issued for the thyroid medication Levothyroxine. The recall was classified as a Class II recall by the Food and Drug Administration. The medication was recalled due to being subpotent.

Major Pharmaceuticals, the manufacturer, issued the recall. Further details about the recall, including affected lots and expiration dates, are available from the FDA's enforcement report. Affected lots include various strengths of Levothyroxine Sodium Tablets with specific lot numbers and expiration dates in 2026.

For more information, readers can refer to the FDA's report.